Serial 90256747
Live / Registered — Registered (as of 10 Aug 2021)
What this means for you
Registered since 10 Aug 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90256747
- Registration number
- 6450587
- Mark type
- Design / logo
- Filed
- 15 Oct 2020
- Published for opposition
- 30 Mar 2021
- Registered
- 10 Aug 2021
- Attorney of record
- John V. Hobgood, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of complement-mediated diseases and disorders
Owner
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
- Apellis Pharmaceuticals, Inc., Waltham, MA, US
Prosecution history
- 10 Aug 2021 — REGISTERED-PRINCIPAL REGISTER
- 08 Jul 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 07 Jul 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jun 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Jun 2021 — USE AMENDMENT FILED
- 21 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jun 2021 — TEAS STATEMENT OF USE RECEIVED
- 25 May 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Mar 2021 — PUBLISHED FOR OPPOSITION
- 10 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Feb 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Feb 2021 — ASSIGNED TO EXAMINER
- 12 Jan 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Jan 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED